Evidence map›Paper›PMID 40496222›Full record

ArticleMedical journal, Armed Forces India

A treated case of high-grade serous adenocarcinoma of ovary recurring as metastatic carcinosarcoma with rhabdomyosarcomatous differentiation.

Shruti Rao, Rahul Dnyandev Dhake, Rashmi Chintan Parikh, Mihir Mohan Vaidya, Shona Nag

Abstract readCase Reports
In one paragraph

Article in Medical journal, Armed Forces India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shruti RaoJunior Consultant (Histopathology), Sahyadri Speciality Labs, Kothrud, Pune, India.
Rahul Dnyandev DhakeConsultant (Histopathology), Sahyadri Speciality Labs, Kothrud, Pune, India.
Rashmi Chintan ParikhConsultant (Histopathology), Sahyadri Speciality Labs, Kothrud, Pune, India.
Mihir Mohan VaidyaConsultant (Histopathology), Sahyadri Speciality Labs, Kothrud, Pune, India.
Shona NagConsultant & Director (Medical Oncology), Sahyadri Superspeciality Hospital, Hadapsar, Pune, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report describes a rare case of high-grade serous carcinoma of ovaries recurring as metastatic carcinosarcoma with heterologous rhabdomyosarcomatous differentiation. A 42-year-old pre-menopausal female patient presented with abdominal fullness and distention. Biopsy from the multiloculated pelvic mass confirmed the diagnosis of high-grade serous carcinoma. The patient underwent neoadjuvant chemotherapy, followed by cytoreductive surgery and post-operative chemotherapy. However, her disease progression was suspected in the follow-up with a raised serum CA-125 level and newly developed metastatic masses on radiology. She was ultimately diagnosed with metastatic carcinosarcoma through repeat biopsy from the internal mammary lymph node. Immunohistochemistry analysis confirmed the rhabdomyosarcomatous differentiation. The literature search reported a limited number of such cases, and none of them from India. This report describes the clinical course, histopathological findings, and treatment details of a patient, along with a brief literature review.

Indexed as

High-grade serous carcinomaMetastatic carcinosarcomaRecurrenceRhabdomyosarcomatous heterologus

Identifiers

PMID40496222
PMCPMC12138076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.